Clinical Trial Update: Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA) [Phase 3]

View source ↗

Summary

Phase 3 CALLA trial evaluating durvalumab with chemoradiotherapy for locally advanced cervical cancer has completed enrollment and posted results in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• IMFINZI (DURVALUMAB)

Snippet

Sponsor: AstraZeneca | Conditions: Locally Advanced Cervical Cancer | Phase 3 | Status: COMPLETED | Results posted: 2023-03-06